1. Home
  2. BTMD vs CCEL Comparison

BTMD vs CCEL Comparison

Compare BTMD & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biote Corp.

BTMD

Biote Corp.

HOLD

Current Price

$1.07

Market Cap

39.0M

Sector

Health Care

ML Signal

HOLD

Logo Cryo-Cell International Inc.

CCEL

Cryo-Cell International Inc.

N/A

Current Price

$4.51

Market Cap

32.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BTMD
CCEL
Founded
2012
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Managed Health Care
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.0M
32.7M
IPO Year
2021
2022

Fundamental Metrics

Financial Performance
Metric
BTMD
CCEL
Price
$1.07
$4.51
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
★ $2.61
N/A
AVG Volume (30 Days)
★ 108.3K
9.9K
Earning Date
11-04-2026
10-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 722.22
N/A
EPS
N/A
★ 0.23
Revenue
★ $192,219,000.00
$25,384,279.00
Revenue This Year
N/A
N/A
Revenue Next Year
$5.45
N/A
P/E Ratio
★ N/A
$19.04
Revenue Growth
N/A
★ 9.76
52 Week Low
$1.00
$2.72
52 Week High
$3.01
$4.90

Technical Indicators

Market Signals
Indicator
BTMD
CCEL
Relative Strength Index (RSI) 38.64 53.80
Support Level $1.00 $3.19
Resistance Level $1.68 $4.76
Average True Range (ATR) 0.10 0.46
MACD 0.01 0.04
Stochastic Oscillator 32.00 70.41

Price Performance

Historical Comparison
BTMD
CCEL

About BTMD Biote Corp.

Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

Share on Social Networks: